Model- Informed Drug Development for Daprodustat Supports the Design of Individualized Dosing Regimens in Chronic Kidney Disease Patients With Anemia. 

Therapeutic area :

Mahar M.K., Yang S., Johnson B., Visser S.A.G., Berg van der P., Noort van N., Post T.M. Model- Informed Drug Development for Daprodustat Supports the Design of Individualized Dosing Regimens in Chronic Kidney Disease Patients With Anemia. Clinical Pharmacology & Therapeutics, 2025 [Link to publication].